Related Experiment Video

Updated: Jul 17, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis

Luis M Moura1, Sandra F Ramos, José L Zamorano

  • 1Hospital Pedro Hispano, Matosinhos, Portugal.

Journal of the American College of Cardiology
|February 6, 2007
PubMed

Insights

Rosuvastatin slowed the progression of moderate to severe aortic stenosis. This prospective study shows statin therapy positively impacts aortic stenosis, improving hemodynamic measures and serum lipids.

Area of Science:

  • Cardiology
  • Pharmacology
  • Medical Research

Background:

  • Retrospective studies suggest statins may slow aortic stenosis progression.
  • Aortic stenosis is a significant cardiovascular condition requiring effective treatment strategies.

Purpose of the Study:

  • To evaluate the effect of a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor on aortic stenosis progression.
  • To assess rosuvastatin's impact on hemodynamic measures and lipid profiles in patients with moderate to severe aortic stenosis.

Main Methods:

  • An open-label, prospective study involving 121 patients with moderate to severe aortic stenosis.
  • Patients were treated with or without rosuvastatin, with measurements taken every 6 months for 18 months.
  • Echocardiography, serum lipids, and inflammatory markers were analyzed.

Main Results:

  • Rosuvastatin treatment resulted in a slower decrease in aortic valve area (p=0.041) and a smaller increase in aortic valve velocity (p=0.007) compared to the control group.
  • Significant improvements in serum lipid profiles and echocardiographic measures of aortic stenosis were observed in the rosuvastatin group.
  • The study demonstrated a statistically significant beneficial effect of rosuvastatin on the hemodynamic progression of aortic stenosis.

Conclusions:

  • Prospective treatment with rosuvastatin effectively slowed the hemodynamic progression of aortic stenosis.
  • This study provides the first prospective evidence supporting statin therapy for aortic stenosis.
  • Targeting serum LDL with rosuvastatin offers a potential therapeutic approach for managing aortic stenosis.
Abstract

More Related Videos

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...